J P Morgan Chase & Co reaffirmed their buy rating on shares of Roche Holding Ltd. (VTX:ROG) in a report released on Thursday morning.

Several other brokerages also recently issued reports on ROG. HSBC Holdings plc set a CHF 203 target price on Roche Holding and gave the company a sell rating in a research note on Friday, October 20th. Sanford C. Bernstein set a CHF 284 target price on Roche Holding and gave the company a buy rating in a research note on Tuesday, July 18th. Berenberg Bank set a CHF 260 target price on Roche Holding and gave the company a neutral rating in a research note on Tuesday, October 24th. Goldman Sachs Group, Inc. (The) set a CHF 325 target price on Roche Holding and gave the company a buy rating in a research note on Monday, September 11th. Finally, Deutsche Bank AG set a CHF 260 target price on Roche Holding and gave the company a neutral rating in a research note on Friday, July 7th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of CHF 263.

Roche Holding (ROG) opened at CHF 232.70 on Thursday. Roche Holding has a 12 month low of CHF 218.30 and a 12 month high of CHF 273.

COPYRIGHT VIOLATION WARNING: “J P Morgan Chase & Co Reaffirms “Buy” Rating for Roche Holding Ltd. (ROG)” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/j-p-morgan-chase-co-reaffirms-buy-rating-for-roche-holding-ltd-rog/1679382.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.